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_ Abstract: The effect of endotoxemia on renal func-
tion was studied in 76 orthotopic liver transplant patients. In 
the preoperative period, a high preoperative serum creati-
nine level 1>2.0 mg/dlj was significantly associated with 
postoperative endotoxemia. The serum total bilirubin level 
was significantly greater in the patients with high serum cre-
atinine levels than in those with lower serum creatinine lev-
els /<2.0 mg/dlj. On the 7th postoperative day /pODj, the 
serum creatinine level was significantly associated with an 
increased plasma endotoxin level. The serum total bilirubin 
and AST levels did not differ significantly between the pa-
tients with high and those with low serum creatinine levels. 
Based upon these data postoperative endotoxemia is sus-
pected as being the principal cause of early postoperative 
renal dysfunction. A synergistic effect on renal function be-
tween cyclosporine and endotoxin may be important in the 
pathogenesis of the renal dysfunction seen after successful 
liver transplantation. 
Introduction 
In human orthotopic liver transplantation (OLTx), patients 
are exposed to a wide variety of nephrotoxic insults dur-
ing the perioperative period before and immediately after 
OLTx (1). In the preoperative period, the most common 
form of renal dysfunction seen in potential transplant can-
didates is functional in nature and is often referred to as 
the hepatorenal syndrome (2). During the transplant pro-
cedure and postoperatively, a panoply of renal insults can 
occur ranging from prerenal conditions such as hypoten-
sion or intrinsic 'renal insults such as occur with the use of 
nephrotoxic agents such as cyclosporine, aminoglycoside 
antibiotics and intravenous contrast agents (3). 
Endotoxin is known to be nephrotoxic. Moreover. endo-
toxemia is often seen in patients with advanced particu-
larly chronic liver disease (4). Endotoxin has been report-
ed to be a major factor contributing to the development 
of functional renal dysfunction associated with liver dis-
ease (5). 
Recent studies have shown that endotoxemia occurs dur-
ing the operative and immediate postoperative periods 
of a liver transplant and is particularly evident during the 
anhepatic phase of the transplant procedure in both ani-
mal (6) and human transplantation (7). 
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A possible role for endotoxemia in the development of 
the early renal dysfunction seen following orthotopic liver 
transplantation is herein proposed based upon clinical 
observations at a large transplant center. 
Materials and methods 
From March 15 to August 15, 1988, 81 patients who un-
derwent orthotopic liver transplantation were selected 
for inclusion in this study. 76 of·these 81 patients sur-
vived greater than 7 days and were studied in detail. The 
selection of the patients for inclusion in this study from 
the larger pool of patients seen at the University of Pitts-
burgh was based solely on the availability of one of the 
investigators (JY). 
The serum creatinine level was measured immediately 
preoperatively and on the morning of the 7th postopera-
tive day. Additionally, the serum total bilirubin and as-
partate aminotransferase (AST) levels were measured at 
these same two time points. 
For all patients, a standard cyclosporine-prednisone im-
munosuppression regimen was used. The cyclosporine 
dose was adjusted daily according to the whole blood 
cyclosporine level measured by the TDX Assay 
System (8). 
Plasma endotoxin was assayed using platelet poor blood 
obtained from a peripheral vein utilizing sterile technique 
and a venipuncture or an indwelling venous catheter. The 
plasma was separated immediately and stored at minus 
800 C until being assayed. The specific endotoxin assay 
utilized was the Iimulus coagulation assay which has 
been described elsewhere (6). 
Statistical AnalysiS: The student t-test was used to deter-
mine differences between groups. A p value <0.05 was 
considered to be Significant. 
Results 
The age of the 76 patients studied ranged from 18 to 66 
years (mean 44). The male to female ratio was 43:33. The 
specific liver disease indications for orthotopic liver 
transplantation in these 76 patients are shown in Table 1. 
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TABLE I. INDICATION OF LIVER TRANSPLANT IN 76 PATIENTS. 
DIAGNOSIS Number of Patients 
Postnecrotic Cirrhosis 38 
Cho/estatic Disease 15 
Fulminant Hepatic Failure 3 
Malignancy 6 
Budd-Chiari syndrome 2 
Primary Graft Failure 12 
TOTAL 76 
TABLE 3. PREOPERATNE LABORATORY VALUES OBTAINED IN 76 
PATIENTS CATEGORIZED INTO THE LOW AND HIGH 
SERUM CREATININE GROUPS EXCLUDING THE 4 
PATIENTS ON HEMOPIALYSIS. 
Laboratory Test 
Plasma Endotoxin 
lPg/mIl 
Total Bilirubin 
Img/d/) 
AST 
I/U/L) 
Serum Creatinine 
low 1< 2.0 mg/dll high 1>2.0 mg/dll 
In=661 In=61 
'8.7 ± 2.9 23.3 ± 5.9 
" "8.0 ± 1.8 "17.2 ± 3.3 
206.9 ± 44.2 130.3 ± 34.3 
• statistically significant difference 
"excluding 4 on hemodialysis. 
The largest single disease indication was postnecrotic cir-
rhosis (35 patients, 46%). Cholestatlc liver disease was 
second; primary graft failure and malignancy were the 
third and fourth most frequent disease indications for 
OLTx. This distribution in disease indications did not dif-
fer from that seen at the University of Pittsburgh In gener-
al. The preoperative creatinine level in the group of pa-
tients undergoing retransplantatlon (3.2+0.9, n=12) was 
greater than that of the patients undergoing primary 
OLTx (1.3+0.2, n=64), (P <0.05). Patients with cholestatic 
liver disease had the lowest preoperative creatinine of all 
the liver disease groups (0.8+0.7, n= 15) (Table 2). The 
preoperative plasma endotoxin level in the group of pa-
tients undergoing retransplantation was significantly 
greater than that seen in any of the other disease groups 
(p<O.Ol) (Table 2). 
Sixty-SiX of the 76 patients studied, survived at least 7 
days postoperatively and had a preoperative serum crea-
tinine <2.0 mg/dl. They were defined as being the low 
serum creatinine group. Four of 10 patients whose preop-
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TABLE 2. PREOPERATNE CREATININE AND ENDOTOXIN LEVELS 
FOR THE VARIOUS LIVER GROUPS. 
LIVER DISEASE n CREATININE ENDOTOXIN 
Img/dll lpg/mIl 
Postnecrotic Cirrhosis 38 1.5 ± 0.2 9.9 ± 1.8 
Cho/estatic Disease 15 0.8± 0.1 12.3 ± 3.0 
Others Budd-Chiaro II 1.4 ± 0.6" 8.0 ± 2.8' 
syndrome, Malignancy 
Primary Graft Failure 12 3.2 ± 0.9 36.9 ± 6.7 
'statistically significant IP<O.O I I 
TABLE 4. POSTOPERATIVE LABORATORY VALUES OBTAINED IN 76 
PATIENTS CATEGORIZED INTO THE 7TH POSTOPERA-
TIVE DAY IN 66 SURVIVING RECIPIENTS WHO HAD LOW 
SERUM CREATININE LEVEL PRIOR TO OLTIC., EXCLUDING 
2 PATIENTS ON HEMODIALYSIS. 
Laboratory Test Serum Creatinine 
low 1< 2.0 mg/dll high 1>2.0 mg/dll 
In=471 In=171 
Plasma Endotoxin '14.4 ± 2.1 43.6± 17.4 
lPg/mil 
Total Bilirubin 6.5 ± 1.2 6.9 ± 1.2 
Img/dll 
AST 928.6 ± 180.5 1132.1 ± 241.8 
IIUIL) 
, 
statistically significant difference 
eratlve creatinine was >2.0 mg/dl) defining them as 
being in the high serum creatinine group required he-
modialysis both before and after OLTx. The immediate 
preoperative plasma endotoxin, serum bilirubin and AST 
levels In the patients with high and low preoperative 
serum creatinine levels excluding the 4 patients on he-
modialysis are shown In Table 3. The preoperative pias-
rna endotoxin and serum bilirubin levels were significant-
ly higher in the high creatinine group (p<O.Ol). 
On the 7th postoperative day (POD), 47 of the 66 pa-
tients who had had a low serum creatinine (<2.0 mg/dl) 
and two of 19 patients whose postoperative creatinine 
was high (>2.0 mg/dl) required hemodialysis. Plasma en-
dotoxin, serum bilirubin and AST levels obtained on the 
7th POD in the patients with high and low postoperative 
serum creatinine levels excluding the 2 patients on he-
modialysis are shown in Table 4. A statistically significant 
greater plasma endotoxin level was seen in the high cre-
atinine group (p<0.05). No significant differences were 
noted between the two groups for either the serum biliru-
-------~--- ----
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bin or the AST level obtained on the 7th POD. 
The serum cyclosporine level on the 7th POD was 
1132.8+ 148.0 ng/ml and 1140.6+ 165.6 ng/ml in those 
with high and low serum creatinine levels, respectively. 
Discussion 
Endotoxin is a lipopolysaccharide derived from the wall 
of gram negative bacteria. The presence of this material 
in the systemic circulation is known to be associated with 
a wide array of adverse biological responses in various 
organs (9). In a recent report, plasma endotoxin levels, 
measurable in systemic blood, were shown to be elevat-
ed following liver transplantation. More importantly, 
markedly elevated endotoxin levels in systemic blood 
has been reported to be associated with an increased rate 
of graft failure (7) as well as an Increased morbidity and 
mortality (10). 
The kidney is known to be one of the target organs for 
endotoxin (11). The pathophysiological features of endo-
toxin induced renal dysfunction are thought to occur 
secondarily to a reduced renal perfusion occurring as a 
consequence of the vasoconstrictor effects of endotoxin. 
These dysfunctions are manifested as a reduction in the 
glomerular filtration rate and to a lesser degree tubular 
injury (12). 
Experimental studies have shown that endotoxin directly 
damages vascular endothelial cells. This injury could be 
the most important mechanism underlying endotoxin in-
duced renal injury (13). 
Cyclosporine which is used as the principal immunosup-
pressive agent following liver transplantation is also 
known to be nephrotoxic. Various-mechanisms for cy-
closporine-induced acute renal failure have been postu-
lated. 
Recently intracapillary glomerular thrombosis has been 
recognized as one of the specific findings in acute cy-
closporine-induced renal injury (14). In animal studies, 
the pathophysiological consequences of such an injury 
have been shown to include an increased renal vascular 
resistance (15), resulting in a reduction in renal perfuSion 
accompanied by a reduction in the glomerular filtration 
rate (16). Similar findings have been reported in the clini-
. cal setting associated with endotoxemia (17-18). 
Another interesting feature of cyclosporine-induced renal 
dysfunction is its association with the hemolytic uremic 
syndrome (19-20). The hemolytic uremic syndrome can 
be produced experimentally by administering endotoxin 
to pregnant rats (21). Subsequent studies have shown 
that cyclosporine acts synergistically with endotoxin to 
produce a state of circulatory collapse and that the ef-
fects of endotoxin on the kidney are additive to the ef-
fects of hypovolemia (22). Cosio et al has shown that cy-
c1osporine treated animals do not develop significant 
renal damage after a single dose of endotoxin, while 
clear cut renal damage occurs when endotoxin is given 
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repeatedly suggesting that a Schwartzman's reaction 
may be the underlying mechanism further renal dysfunc-
tion under this set of circumstances (23). 
The results of the present study suggest that endotox-
emia may be responsible for some of the renal dysfunc-
tion seen both pre- and postoperatively in a liver trans-
plant population. In the preoperative period, liver dys-
function per is the underlying mechanism for the endo-
toxemia and associated renal dysfunction. Postoperative-
ly, endotoxemia possibly coupled with cyclosporine ap-
pears to be an important factor associated with the pres-
ence of clinically significant renal dysfunction. 
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